Neoplasms

3,817 trials 1,526 recruiting

Filter these 3,817 trials by phase, country and sponsor.

Open in Search →

Testing two different drugs (sacituzumab-govitecan and trastuzumab-deruxtecan) combinations prescribed in an alterning pattern to patients w… Pending

2025-521909-40-00 Patients with metastatic or locally advanced HER2-low t 4
A phase 2, single arm, open label, study on the safety and feasibility of Liver Isolated Oxaliplatin (LIOX) delivered via arterial access de… Pending

2025-523261-25-00 colorectal cancer 4
A Phase 1/2 Study of BMS-986525 with and without Nivolumab in Relapsed/Refractory Small Cell Lung Cancer Pending

2025-524090-16-00 Relapsed/Refractory Small Cell Lung Cancer 7
Unravelling the invisiBle infiltRating cOmponeNT Of glioblaStomA Using mRi USpio (BRONTOSAURUS) Pending

2024-514013-34-00 Glioblastoma 6
Brain cancer and changes in immune system Pending

2024-512136-30-00 Glioblastoma multiforme 6
Targeting inflammation to reduce 90-day and 1-year postoperative severe morbidity in patients with unfavorable inflammatory profile undergoi… Pending

2024-515333-14-03 Patients scheduled for major surgery for oncologic indi 4
Neoadjuvant pembrolizumab in patients with stage IIb/c melanoma, a phase II double-blind placebo-controlled randomized trial NEOPRIME Pending

2024-519594-19-00 Stage IIb/c melanoma 4
Intensive Intraperitoneal Therapy in Advanced Ovarian Cancer Pending

2024-515339-30-00 Ovarian Cancer 4
LEAn Body Mass Normalization of OXaliplatin Based Chemotherapy Pending

2024-515340-23-00 Colon cancer 4
A Multicentre, Randomised Phase Ib Trial to evaluate Neoadjuvant Immunotherapy Combination of Nivolumab alone or plus Ipilimumab with the IL… Pending

2024-519010-31-00 High-Risk, Surgically Resectable Melanoma 3
Multicenter, randomized, double-blinded, placebo-controlled phase 3 trial to evaluate nonavalent HPV vaccine as a secondary prevention in pa… Pending

2024-520140-42-00 Patients with primary HPV high-grade squamous intra-epi 5
CELL-BASED IMMUNOTHERAPY FOR TREATMENT OF TRIPLE NEGATIVE BREAST CANCER STAGES II AND III Pending

2023-506019-16-03 TRIPLE NEGATIVE BREAST CANCER 7
Artesunate, sulfasalazine polyunsaturated fatty acids, and iron in patients with solid tumors. Pending

2024-519602-12-01 Cancer 3
The PACMAN-Hu19 trial: a phase I/II study with locally produced CD19-targeted CAR T-cell therapy Pending

2023-507597-40-00 B-cell precursor ALL 9
A clinical trial to learn more about the effects of DJI136 in people with extensive-stage small cell lung cancer Pending

2025-523276-23-00 Extensive stage small cell lung cancer 7
Tumour heterogeneity studies based on dedicated breast PET using proliferation radiotracers: early detection of the treatment response. Pending

2024-512152-38-00 Breast cancer 9
Repeated Mesenchymal Stem Cell Therapy for Radiation-Induced Hyposalivation and Xerostomia in Head and Neck Cancer Survivors Pending

2025-522559-25-00 Xerostomia due to readiotherapy for a head & neck cance 4
DETECTION RATE AND CLASSIFICATION OF BREAST LESIONS WITH DIGITAL MAMMOGRAPHY WITH CONTRAST MEDIUM (CEDM) ALONE AND IN COMBINATION WITH TOMOS… Pending

2024-519017-62-00 breast pathology 4
ENDO-67 project: Investigating ENDOcrine therapy-related questions using Ki67 changes in the window-of-opportunity before breast surgery Pending

2025-521385-10-00 Breast cancer 6
Revumenib Treatment in Combination with FLA Chemotherapy in Paediatric Refractory/Relapsed KMT2A-r, NUP98-r or NPM1-mut Acute Myeloid Leukem… Pending

2025-521390-14-00 Acute Myeloid Leukemia 4
A trial to learn how well AZD0120 works and how safe it is in people with relapsed or refractory multiple myeloma. Pending

2025-523285-25-00 Relapsed or Refractory Multiple Myeloma 5
Study to find out whether adding the medicine Naxitamab to standard treatment could help children and teenagers who have just been diagnosed… Pending

2025-524140-35-00 Neuroblastoma or ganglioneuroblastoma (nodular or inter 4
Atezolizumab, Pertuzumab and Trastuzumab with chemotherapy as neoadjuvant treatment of HER2 positive early high-risk and locally advanced br… Pending

2024-518026-32-00 Invasive Breast Cancer 5
The MAYA2 trial Pending

2025-521941-25-00 Colorectal cancer 4